Apatinib igecycline Hydrochloride Ibandronate is efficacious for the

Ibandronate is efficacious for the prevention of metastasis-related bone fractures in multiple myeloma

inhibits survival of cancer cell lines

2009 Oct-Dec

InChi: InChI=1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14

Apatinib igecycline Hydrochloride Ibandronate is efficacious for theApatinib, also known as Rivoceranib, is an orally bioavailable, small molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. The free base form is also known as Rivoceranib. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this